The First Affiliated Hospital of Nanchang University
🇨🇳China
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Acute Pancreatitis
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-02-06
- Target Recruit Count
- 60
- Registration Number
- NCT06639516
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
Not yet recruiting
- Conditions
- Acute Pancreatitis
- First Posted Date
- 2024-01-30
- Last Posted Date
- 2024-01-30
- Target Recruit Count
- 176
- Registration Number
- NCT06230432
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Target Recruit Count
- 30
- Registration Number
- NCT06118762
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy
Phase 4
Active, not recruiting
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: Lacidophilin tablets in combination with vonorazan dual therapyDrug: Placebo in combination with vonorazan dual therapy
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2024-06-18
- Target Recruit Count
- 324
- Registration Number
- NCT05749081
- Locations
- 🇨🇳
The first affiliated hospital, Jiangxi Medical College, NanChang University, Nanchang, Jiangxi, China
Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
Not Applicable
Recruiting
- Conditions
- Advanced Malignant Solid Tumors
- Interventions
- Drug: Neoantigen-based DC immune preparation
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2025-02-27
- Target Recruit Count
- 20
- Registration Number
- NCT05749627
- Locations
- 🇨🇳
First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Helicobacter Pylori and Vonoprazan Dual Therapy
Phase 4
Completed
- Conditions
- Helicobacter Pylori
- Interventions
- Drug: H-VA dual therapyDrug: L-VA dual therapy
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2024-08-23
- Target Recruit Count
- 504
- Registration Number
- NCT05649709
- Locations
- 🇨🇳
The First Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China
Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane（IMPLANE-0529）
Not Applicable
Recruiting
- Conditions
- SegmentectomyNon-small Cell Lung Cancer Stage I
- Interventions
- Procedure: Indocyanine green fluorescence imaging methodProcedure: Modified inflation-deflation method
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2023-09-13
- Target Recruit Count
- 272
- Registration Number
- NCT05453721
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Timing of Transmural Stent Removal in Necrotizing Pancreatitis
Not Applicable
Not yet recruiting
- Conditions
- Walled-Off NecrosisNecrotizing PancreatitisAcute Pancreatitis
- Interventions
- Procedure: Stent removed by the novel strategyProcedure: Stent removed by the conventional strategy
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Target Recruit Count
- 156
- Registration Number
- NCT04963868
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding
Completed
- Conditions
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2021-05-20
- Target Recruit Count
- 3200
- Registration Number
- NCT04895904
Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas
Phase 1
- Conditions
- Acute Lymphoblastic Leukemia ,Lymphomas
- Interventions
- Biological: Anti-CD19 CAR-T
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2019-12-12
- Target Recruit Count
- 20
- Registration Number
- NCT04196205
- Locations
- 🇨🇳
The First Affiliated Hospital of Nangchang University, Nanchang, Jiangxi, China